SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹31 Cr | ₹21 Cr | ₹22 Cr | ₹14 Cr | ₹12 Cr |
What is the latest Sundry Debtors ratio of SAKAR HEALTHCARE ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹12 Cr |
How is Sundry Debtors of SAKAR HEALTHCARE Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 46.91 | |
| Mar2024 | ₹21 Cr | -5.27 | |
| Mar2023 | ₹22 Cr | 55.66 | |
| Mar2022 | ₹14 Cr | 14.61 | |
| Mar2021 | ₹12 Cr | - | |
Compare Sundry Debtors of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,829.5 Cr | 7.4% | 37.5% | 152.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 7.4% |
37.5% |
152.3% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses